SCHEMBL7304520

SCHEMBL7304520

COc1ccc([C]=O)c(C(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.42
HTT P42858 1/20 0.41
ADRA2A P08913 2/20 0.40
ADRA1A P35348 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ACHE P22303 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2A6 P11509 1/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
LPAR1 Q92633 2/20 0.38
P2RX3 P56373 1/20 0.38
P2RX2 Q9UBL9 1/20 0.38
PTGS2 P35354 3/20 0.37
PTGS1 P23219 2/20 0.37
AKR1C3 P42330 2/20 0.37
AKR1C2 P52895 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19833573 0.81 KDM4E (0.46) CYP2D6MEN1KMT2A
SCHEMBL25072790 0.81 CYP2D6 (0.42) CYP2D6HTTADRA2AADRA1ACA1
SCHEMBL11508000 0.78 CA12 (0.43) CA1CA2CYP1A2CYP2A6MEN1
SCHEMBL10304814 0.76 CYP2D6 (0.50) CYP2D6HTTADRA2AADRA1ACA1
SCHEMBL2704176 0.75 ACACB (0.43) HTTCA1CA2ACHECYP1A2
SCHEMBL1799316 0.75 CA12 (0.56) CYP2D6HTTADRA2AADRA1ACA1
SCHEMBL7678208 0.75 FABP3 (0.44) HTTCA1CA2CYP1A2PTGS1
SCHEMBL96290 0.75 CA12 (0.56) CYP2D6HTTCA1CA2CYP1A2
SCHEMBL16472139 0.74 CYP2D6 (0.42) CYP2D6HTTADRA2AADRA1ACA1
SCHEMBL8830135 0.73 RECQL (0.36) CYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5773456-A EMPHYSEMA, RHEUMATOID ARTHRITIS AND PANCREATITIS SANOFI (FR) 1998-06-30 US disclosed
US-5578623-A DRUGS FOR TREATMENT OF ARTHRITIS, PANCREATITIS, CYSTIC FIBROSIS, BRONCHITIS, RESPIRATORY DISORDERS STERLING WINTHROP INC. (US) 1996-11-26 US disclosed
US-5464852-A Used in treatment of degenerative diseases STERLING WINTHROP INC. (US) 1995-11-07 US disclosed
US-5380737-A Enzyme inhibitors STERLING WINTHROP INC. (US) 1995-01-10 US disclosed
EP-0542371-A1 Saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP disclosed